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142Objectives: Delayed first-stage palliation of children with hypoplastic left heart syndrome and related pathol-
ogies can be associated with poor outcomes because of development of progressive pulmonary vascular disease
and volume load effects on the systemic ventricle and atrioventricular valve. We examine the current era’s
survival in this subgroup.
Methods: Fifty-five infants older than 2 weeks underwent the Norwood operation (2003–2007). Separate com-
peting risk analyses were performed to model outcomes (death and transition to the next stage) after the Nor-
wood operation and after bidirectional cavopulmonary connection.
Results:Median agewas 32 days (range, 15–118 days). Forty-seven percent had hypoplastic left heart syndrome,
and 53% had other complex univentricular variants. Mean ascending aortic size was 4.4 1.9 mm, 10% had im-
paired ventricular function, 11% had moderate atrioventricular valve regurgitation, and 32% had restrictive pul-
monary venous return. Pulmonary blood flow was established through an aortopulmonary shunt (n¼ 30) or Sano
shunt (n¼ 25). After the Norwood operation, patients required longer ventilation and more oxygen and nitric ox-
ide and had higher inotropic scores compared with those undergoing the traditional management protocol. Com-
peting risks analysis showed that 2 years after the Norwood operation, 39% had died, and 57% underwent
bidirectional cavopulmonary connection. Four years after bidirectional cavopulmonary connection, 15% had
died, and 85% underwent the Fontan operation. Overall 3-year survival after the Norwood operation was
53%. Factors associated with mortality were age, lower weight at the time of the Norwood operation, impaired
ventricular function, longer circulatory arrest, and lower pre–bidirectional cavopulmonary connection saturation.
Conclusions: Children older than 2 weeks undergoing the Norwood operation frequently require postoperative
pulmonary vasodilatation and high inotropic support. A significant hazard of death persists through all steps of
multistage palliation. Increased pulmonary vascular resistance and volume load effects, such as systemic ventric-
ular impairment and atrioventricular valve regurgitation, are commonly evident in patients in whom treatment
fails or who do not qualify to proceed to the next stage of palliation. Those patients should be closely monitored
for timely referral for heart transplantation when indicated. (J Thorac Cardiovasc Surg 2011;142:142-7)Supplemental material is available online.
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The Journal of Thoracic and Cardiovascular Surgcomplex, single-ventricle malformations in the majority
of cardiac centers.1-6 Results of first-stage palliation have
significantly improved in the last decade because of refine-
ments in preoperative care, surgical and perfusion
techniques, postoperative care, and monitoring.7-15
Several previous reports have demonstrated that first-stage
palliation performed in infants older than 2 to 4 weeks of age
is associated with a significant increase in mortality.2-4,6,16
This was ascribed to the development of pulmonary
vascular disease, which complicated the postoperative
course and predisposed the infants to potentially fatal
pulmonary hypertensive crises in addition to the effects of
prolonged volume load on the single ventricle with
subsequent dysfunction and on the atrioventricular valve
(AVV) with subsequent regurgitation, with a significant
negative effect on early and late outcomes.17,18
Despite multiple existing current large series demonstrat-
ing improved results of first-stage palliation, the number ofery c July 2011
Abbreviations and Acronyms
AVV ¼ atrioventricular valve
BCPC ¼ bidirectional cavopulmonary
connection
ECMO ¼ extracorporeal membrane oxygenation
FIO2 ¼ fraction of inspired oxygen
HLHS ¼ hypoplastic left heart syndrome
mBTS ¼ modified Blalock–Taussig shunt
PE ¼ parameter estimate
PVR ¼ pulmonary vascular resistance
RV–PA ¼ right ventricle–pulmonary artery
SE ¼ standard error
Alsoufi et al Congenital Heart Diseaseinfants older than 2weeks at the time of first-stage palliation
in those series is small because the majority of those pa-
tients undergo surgical intervention within the first week
of age.7-15 In the present report we aim to describe the
outcomes of infants older than 2 weeks of age at the time
of first-stage palliation in the current era and examine fac-
tors associated with increased hazards of mortality.C
H
DMATERIALS AND METHODS
Inclusion Criteria
From 2003 to 2007, 55 consecutive infants with variable single-
ventricle pathologies underwent Norwood-type first-stage palliation at an
age of greater than 14 days at the King Faisal Specialist Hospital and Re-
search Center in Riyadh, Saudi Arabia. Clinical, operative, and outcome
data were abstracted from patients’ medical records. Approval of this study
was obtained from the research ethics board at our institution, and require-
ment for individual consent was waived for this observational study.
Operative Details
The surgical procedure consisted of standard first-stage Norwood palli-
ation with division of the main pulmonary artery and side-to-side anasto-
mosis with the ascending aorta, aortic arch augmentation and
reconstruction, and atrial septectomy. Pulmonary blood flow was estab-
lished with either a modified Blalock–Taussig shunt (mBTS) or a right ven-
tricle–pulmonary artery (RV–PA) conduit based on the individual
surgeon’s preference. During arch reconstruction, deep hypothermic circu-
latory arrest and selective antegrade cerebral perfusion, isolated or in com-
bination, were used at the surgeon’s discretion.
Follow-up
Time-related outcomes were determined from recent office visits at
King Faisal Specialist Hospital and Research Center and from direct corre-
spondence with patients’ families. Follow-up was complete. Mean follow-
up was 2.2 2.1 years for the entire cohort and 2.8 2.0 years for patients
who survived to hospital discharge after the first stage.
Statistical Analysis
Data are presented as means with standard deviations, medians with
minimums and maximums, and frequencies, as appropriate. Time-
dependent mutually exclusive outcomes (death and survival to the next
stage of palliation) after first-stage palliation and after bidirectional cavo-
pulmonary connection (BCPC) were parametrically modeled. Parametric
probability estimates for time-dependent outcomes use models based on
multiple overlapping phases of risk (available for use with the SAS systemThe Journal of Thoracic and Caat http://www.clevelandclinic.org/heartcenter/hazard). The HAZARD pro-
cedure uses maximum likelihood estimates to resolve risk distribution of
time to event in up to 3 phases of risk (early, constant, and late). Competing
risk analysis was performed to model the probability over time of each of 2
mutually exclusive end points after first-stage palliation and after BCPC:
death and survival to the next stage of palliation and the remaining patients
beginning alive and not qualifying for the next stage of palliation. Variables
potentially influencing the likelihood of outcomes in the competing risk
models were sought from demographic, anatomic, and surgical variables
through a stepwise regression algorithm (P<.05 to enter) for each phase
of risk. Effects of covariates on the probability of outcomes in competing
risk models are given as parameter estimates (PEs) and standard errors
(SEs). The clinical relevance of covariates of interest on likelihood of se-
lected outcomes was established by solving the regression equations for
multiple ‘‘typical’’ test patients. All statistical analyses were performed
with SAS statistical software version 9.1 (SAS Institute, Inc, Cary, NC).RESULTS
Patient Cohort
During the study period, 55 infants older than 14 days un-
derwent Norwood-type first-stage palliation. There were 37
(65%) male and 18 (35%) female patients. The age range
was 15 to 118 days and included 12 patients 2 to 3 weeks
old, 12 patients 3 to 4 weeks old, and 31 patients more
than 4 weeks old. Complete patients’ characteristics are de-
tailed in Table 1.
First-Stage Palliation
At the time of first-stage palliation, pulmonary blood
flow was restored by means of mBTS in 29 (54%) patients
and by means of an RV–PA conduit in 24 (44%) patients,
with 1 (2%) patient requiring both. One patient in whom
the shunt type is not well documented died in the operating
room. Mean mBTS diameter was 3.9  0.3 mm, and mean
RV–PA conduit size was 5.7 0.5 mm.Mean cardiopulmo-
nary bypass time was 139 43 minutes, mean aortic cross-
clamp time was 68  20 minutes, and mean deep
hypothermic circulatory arrest time was 42  22 minutes.
Five patients required postoperative extracorporeal mem-
brane oxygenation (ECMO), and none of them survived.
Three patients required shunt revision, and 2 of them
died. Other reoperations included diaphragmatic plication
in 5 patients and evacuation of a seroma compressing on
the shunt and pulmonary arteries in 1 patient.
Inotrope use was quantified by a revised score adapted
from Wernovsky and colleagues.19 The score was calcu-
lated by obtaining the average amount of inotropic support
the patients received at the first 3 postoperative days
(excluding patients receiving ECMO support) and then
entering the data into the following equation:
Inotrope score: DopamineþDobutamineþð½Epinephrine
þNorepinephrine 3100ÞþðMilrinone 3 20Þ:
Units of inotrope dosage used in this equation were in mi-
crograms per kilogram per minute. The average inotropicrdiovascular Surgery c Volume 142, Number 1 143
TABLE 1. Complete characteristics for the entire patient cohort
(n ¼ 55)
Age at first-stage palliation (d), median (range) 32 (15–118)
Male sex, n (%) 37 (65)
Mean weight (kg) 3.1  0.6
Diagnosis
HLHS, n (%) 26 (47%)
Non-HLHS, n (%) 29 (53%)
Double-inlet left ventricle 11
Double-outlet right ventricle 6
Severe Shone complex 3
Unbalanced atrioventricular septal defect 2
Tricuspid atresia 2
Other 5
Dominant ventricular morphology, n (%)
Left 17 (31%)
Right 38 (69%)
Dominant ventricular function
Normal 90%
Mildly impaired 4%
Moderately impaired 6%
Dominant atrioventricular valve function
Competent or trivial regurgitation 63%
Mild regurgitation 26%
Moderate regurgitation 11%
Aortic atresia 28%
Mitral atresia 31%
Restrictive pulmonary venous return 32%
Ascending aortic diameter (mm) 4.4  1.9
Situs inversus/dextrocardia 1
Interrupted aortic arch 2
Genetic syndrome 0
Extracardiac malformations 0
HLHS, Hypoplastic left heart syndrome.
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for first-stage survivors (32  14 per day) versus nonsurvi-
vors (58  44 per day, P< .0001). The average oxygen
saturation in the first 3 days was 70%  6%, and the aver-
age fraction of inspired oxygen (FIO2) was 50%  16 %.
Nitric oxide use was required in 12 patients. Median venti-
lation duration in first-stage survivors was 18 days (range,
2–108 days).
The difference in postoperative parameters between first-
stage hospital survivors versus nonsurvivors is shown in
Table 2.TABLE 2. Postoperative care parameters after first-stage palliation in inf
Overall
Average 3-d inotropic score* 38  26/d
Average 3-d oxygen saturation 70%  6%
Average 3-d FIO2 use 50%  16%
Average 3-d oxygen saturation/FIO2 ratio 1.6  0.6
Nitric oxide use 12 patients
All units are in micrograms per kilogram per minute. FIO2, Fraction of inspired oxygen. *I
(Milrinone 3 20).
144 The Journal of Thoracic and Cardiovascular SurgCompeting Risk Analysis After First-Stage Palliation
After the 55 initialNorwood-typefirst-stage palliative pro-
cedures, 31 (56%) patients underwent BCPC, and 22 (40%)
patients died before BCPC. In addition, 1 (2%) patient in
whom the superior vena cava was obstructed proceeded im-
mediately to the Fontan operation and, 1 (2%) remaining pa-
tient remains alive but did not qualify for BCPC because of
severe neurologic insult after a central nervous system infec-
tion that was unrelated to the cardiac procedure.
The competing risks analysis after first-stage palliation
showed that at 1year after first-stage palliation, approximately
37% of patients had died, and 54% had undergoneBCPC.By
2 years after first-stage palliation, 39% have died, and 58%
have proceeded to the next stage of palliation (Figure 1).
Factors associated with higher mortality after first-stage
palliation were sought, and results are shown in Table 3.
Significant factors for mortality included lower weight
(PE,þ0.84 [SE, 0.41]; P ¼ .04), longer deep hypothermic
circulatory arrest (PE,þ0.20 [SE, 0.09]/10 min; P ¼ .03),
impaired dominant ventricular function (PE, þ1.20 [SE,
0.57]; P ¼ .04), and age category less than 3 weeks (PE,
þ1.05 [SE, 0.46], P ¼ .03).Competing Risks Analysis After Second-Stage
Palliation
Thirty-one patients underwent BCPC. Hemodynamic
and echocardiographic parameters before BCPC are listed
in Table E1. BCPC was right sided (n ¼ 28), left sided
(n¼ 1), and bilateral (n¼ 2). Eight patients had preparation
for a subsequent interventional Fontan operation at the time
of BCPC. Additional cardiac procedures were performed in
15 patients and included pulmonary artery augmentation
(n ¼ 12), arch augmentation (n ¼ 1), AVV repair (n ¼ 2),
AVV closure (n ¼ 1), and permanent pacemaker insertion
(n ¼ 1). One patient required postoperative takedown of
the BCPC and placement of an mBTS because of increased
pulmonary vascular resistance (PVR).
After the 31 BCPC procedures, 26 (84%) patients under-
went the Fontan procedure, and 5 (16%) patients died be-
fore the Fontan procedure. The competing risks analysis
after second-stage palliation showed that at 2 years after
second-stage palliation, approximately 15% of patients
had died, and 43% had undergone the Fontan procedure,
with the remaining 43% alive and awaiting the Fontanants older than 2 weeks at the time of the operation
Survivors Nonsurvivors P value
32  14/d 58  44/d <.0001
71%  6% 68%  9% .02
48%  14% 58%  20% .10
1.6  0.6 1.4  0.7 .50
7 patients 5 patients
notrope score: DopamineþDobutamineþ([EpinephrineþNorepinephrine] 3 100)þ
ery c July 2011
FIGURE 1. Competing risks depiction of events (death and transition to
bidirectional cavopulmonary connection, with the remaining few patients
alive and awaiting bidirectional cavopulmonary connection or transitioning
directly to the Fontan operation) after Norwood-type first-stage palliation
of HLHS and related pathologies in infants greater than 2 weeks of age.
FIGURE 2. Competing risks depiction of events (death and transition to
the Fontan operation) after bidirectional cavopulmonary connection
(BCPC) in infants who underwent Norwood-type first-stage palliation at
greater than 2 weeks of age.
Alsoufi et al Congenital Heart Diseaseprocedure. By 4 years after second-stage palliation, 15%
have died, and the remaining 85% have proceeded to the
Fontan procedure (Figure 2).
Factors associated with higher mortality after BCPC
were sought, and results are shown in Table 3. Significant
factors for mortality included smaller ascending aortic
size (PE,þ0.82 [SE, 0.42]/mm; P ¼ .05), higher pre–Glenn
procedure transpulmonary gradient (PE,þ0.20 [SE, 0.11]/
mm Hg; P ¼ .06), and age category less than 3 weeks atTABLE 3. Risk factors for death in patients older than 2 weeks at first-
stage palliation
Parameter
estimate
(standard error)
P
value
1. Factors associatedwith death after theNorwoodoperation (beforeBCPC)
Longer DHCA time (per 10 min) 0.20 (0.09) .03
Lower weight at time of operation (per kg) 0.84 (0.41) .04
Impaired dominant ventricular function 1.20 (0.57) .04
Age group<3 wk 1.05 (0.46) .03
2. Factors associated with death after BCPC (before the Fontan procedure)
Higher transpulmonary gradient 0.20 (0.10) .06
Smaller ascending aortic size 0.82 (0.42) .05
Age group<3 wk at time of Norwood
operation
1.94 (0.92) .04
3. Factors associated with overall mortality
Age group<3 wk at time of Norwood
operation
0.48 (0.24) .05
Impaired dominant ventricular function 0.99 (0.53) .06
Lower weight category (<2.5 vs>2.5 kg) 0.57 (0.32) .07
Longer DHCA time (min) 0.03 (0.01) .01
Lower oxygen saturation before BCPC
(per%)
0.06 (0.04) .09
DHCA, Deep hypothermic circulatory arrest; BCPC, bidirectional cavopulmonary
connection.
The Journal of Thoracic and Cathe time of the Norwood operation (PE,þ1.94 [SE, 0.92];
P ¼ .04).
Of note, 3 patients died after the Fontan procedure, 2 in
the perioperative period and 1 after reoperation for pulmo-
nary venous obstruction. Hemodynamic and echocardio-
graphic parameters before the Fontan procedure are listed
in Table E1.C
H
DOverall Survival
Overall 3-year survival after first-stage palliation was
53%. The hazard function for death was characterized by
a pronounced early hazard phase in the immediate postop-
erative period but a persistent constant hazard phase that
continued up to 1.5 years after first-stage palliation
(Figure 3).
Factors associated with overall mortality are shown in
Table 3. The relationship between overall survival and pa-
tient weight at the time of the operation is shown in
Figure E1. Of note, there were trends for decreased survival
in patients with dominant right ventricular morphology
(Figure E2) and with the use of an RV–PA conduit
(Figure E3), although those trends did not reach statistical
significance. The events after first-stage palliation in the en-
tire cohort of patients is shown in Figure E4.DISCUSSION
Despitemultiple reports fromdifferent institutions demon-
strating significant improvement in hospital survival after
first-stage palliation of HLHS and other complex single-
ventricle pathologies, little information is available regarding
contemporary outcomes in infants older than 2 weeks at the
time of the operation.7-15 Older age was identified as
a significant risk factor for hospital and interstage mortalityrdiovascular Surgery c Volume 142, Number 1 145
FIGURE 3. Time-dependent survival (A) and hazard risk of death (B)
over time after Norwood-type first-stage palliation. The hazard function
for death is characterized by the presence of an early hazard phase during
the initial few months after surgical intervention. After that period, there is
a constant attrition that continues up to 2 years after the initial operation.
The solid lines in the parametric model represent parametric point esti-
mates, and the dashed lines enclose the 95% confidence interval. Circles
represent nonparametric estimates.
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current large series contain few patients older than 2 weeks
at the time of the Norwood operation, and therefore it is not
clear whether this subgroup of patients benefited from this
recent trend of superior results.7-15
At our institution, we continue to assess many patients
with various complex single-ventricle anomalies at older
ages because of the tertiary nature of our practice as the
sole provider for Norwood-type palliation in the region.
Our unique experience prompted us to review contemporary
outcomes in a relatively large consecutive cohort of older
infants at the time of first-stage palliation. Surgical delays
in our current series were not related in general to poor pre-
operative status, sepsis, or multiorgan failure but rather to
late presentation or referral.146 The Journal of Thoracic and Cardiovascular SurgOne of our principal findings was the distinctive postoper-
ative course in this subgroup of patients. The mainstay of
postoperative treatment after the Norwood operation is
achieving a balance between the pulmonary and systemic cir-
culations. Systemic afterload reduction and ventilator man-
agement to avoid pulmonary overcirculation are commonly
used in the postoperative care of neonates after the Norwood
operation.7,14,15 In our older patients, however, a different
treatment philosophy is often required. Many of our
patients exhibit signs of poor pulmonary circulation and
require high oxygen concentrations and pulmonary
vasodilators, such as nitric oxide, to promote blood flow to
the lungs. In addition, there is often very little room for
systemic vasodilatation, and those infants often require
inotropic support and vasopressors, as demonstrated by the
high inotropic score in the initial 3 postoperative days. This
distinct postoperative requirement can be explained by the
effects of delayed surgical intervention, such as the
development of progressive pulmonary vascular disease,
chronic volume load causing development of postoperative
ventricular dysfunction, or AVV regurgitation. Moreover,
older infants in our series required high oxygen
concentration, had low oxygen saturation, and required
prolonged ventilation and subsequent prolonged intensive
care unit and hospital stays. ECMO support was largely
ineffective in our patient population, especially because the
heart transplantation option was not offered to this age
group at our institution.
Additionally, we noted a high interstage mortality in our
patient cohort, with only 60% of all patients proceeding to
the next stage of palliation. This high interstage mortality in
older infants has been noted by other investigators. Hehir
and colleagues16 showed that the Norwood operation at
greater than 7 days of age is a significant risk factor for in-
terstage mortality. In addition to residual lesions and shunt-
related problems,13,20 high PVR and a reactive pulmonary
vascular bed expose those infants to the risk of pulmonary
hypertension crises that can be often fatal and might be
implicated in this high occurrence of interstage mortality.
We have noted many incidents of pulmonary hypertension
in our patient cohort while in the hospital with subsequent
respiratory and hemodynamic compromise, cardiac arrest,
and occasional mortality. This tendency likely continues
after discharge to contribute to this disturbingly high rate
of sudden death at home.
Although the risk of mortality is usually greatly elimi-
nated when a balanced circulation is achieved by means
of BCPC with eradication of shunt problems, coronary steal
risk, volume load effects, and management of any residual
lesions.3,6,13 In our series we observed that those older
patients do not enjoy this stabilization of mortality risk
with time, and the hazard of death continues after BCPC
almost up to 2 years after the Norwood procedure.
Pulmonary vascular disease, ventricular dysfunction, andery c July 2011
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DAVV regurgitation were evident in most patients who did
not progress to the next stage of palliation or died after
subsequent palliative procedures in our series. This
finding highlights the importance of continued close
follow-up of those patients for timely referral for heart
transplantation when indicated.
Several demographic, anatomic, operative, and hemody-
namic variables were analyzed to determine factors that sig-
nificantly affect survival. Some trends that did not reach
statistical significance merit some discussion. We have
noted that patients who received mBTSs as a source of pul-
monary blood flow at the time of first-stage palliation had
a trend for improved survival compared with those who re-
ceived RV–PA conduits. Although RV–PA conduits have
been shown to facilitate postoperative care and even to de-
crease early mortality in some series,8,11,12 this was not the
case in older patients in our series. The benefit of the RV–
PA conduit is diluted in this subgroup of patients in whom
pulmonary overcirculation and subsequent coronary steal
are not major problems. In addition, lower saturations
achieved by the RV–PA conduit, especially in the setting
of increased PVR, and the effects of ventriculotomy,
especially in those patients with ventricular dysfunction
caused by chronic volume load, might all contribute to
the surprisingly worse survival seen in older patients who
received RV–PA conduit.
We have also noted that patients with dominant left ven-
tricular morphology had a trend toward improved survival.
This finding might be explained by the fact that morpho-
logic left ventricles are more equipped to tolerate higher
afterload and volume load and therefore might be more re-
silient to the sequelae of delayed first-stage palliation.
Of interest, the outcomes in the oldest patients in our se-
ries, those older than 4 weeks, were not worse than those 2
to 4 weeks old. This might be explained by a more selective
approach to the older patients at our institution but defi-
nitely highlights that the development of pulmonary vascu-
lar disease is unpredictable and that the relationship
between PVR and age in days is not linear, at least within
the age margins of our patient cohort.
In conclusion, infants older than 2 weeks at the time of
Norwood-type first-stage palliation comprise a unique sub-
group of patients. Postoperative care is different from tradi-
tional management, with a higher likelihood of requirement
of inotropes, vasopressors, and pulmonary vasodilators. De-
spite improved outlook of patients undergoing Norwood-
type operations in the recent era, older infants at the time
of first-stage palliation continue to be exposed to the hazard
of death that continues beyond the perioperative and inter-
stage periods and throughout all steps of multistage pallia-
tion. This vulnerability is mostly the product of delayed
operation because of the development of pulmonary vascu-
lar disease and ventricular dysfunction. Careful preopera-
tive assessment of those infants is necessary for selectionThe Journal of Thoracic and Caof the most appropriate procedure, and vigilant follow-up
is necessary for timely referral for heart transplantation,
as indicated in patients not proceeding to the next stage of
palliation.References
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FIGURE E1. Parametric model for survival after first-stage palliation
stratified by weight group at the time of the initial operation. Lower weight
was associated with higher mortality.
FIGURE E2. Parametric model for survival after first-stage palliation
stratified by dominant ventricular morphology. There was a trend for im-
proved survival in patient with dominant left ventricular morphology com-
pared with that seen in patients with dominant right ventricular
morphology.
FIGURE E3. Parametric model for survival after first-stage palliation
stratified by the type of shunt at the time of first-stage palliation. There
was a trend for improved survival in patients who had a modified Bla-
lock–Taussig shunt compared with that seen in patients who had a right
ventricle–pulmonary artery conduit (Sano shunt).
FIGURE E4. Flow chart depicting events after first-stage Norwood-type
palliation in 55 infants older than 2 weeks of age at the time of the opera-
tion. BCPC, Bidirectional cavopulmonary connection.
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TABLE E1. Echocardiographic and hemodynamic parameters before BCPC and before the Fontan procedure
Pre-BCPC (n ¼ 33) Pre-Fontan (n ¼ 27)
Mean PA pressure (mm Hg) 17  5 14  3
Mean ventricular EDP (mm Hg) 10  3 10  3
Mean transpulmonary gradient (mm Hg) 7  5 4  3
PVR index (Woods units) 2.3  1.2 1.7  0.8
Oxygen saturation (%) 70  8 83  5
AVV regurgitation Mild ¼ 17 (52%)
Moderate ¼ 3 (9%)
Mild ¼ 3 (11%)
Moderate ¼ 2 (7%)
Dominant ventricular function Mildly impaired ¼ 3 (9%)
Moderately impaired ¼ 3 (9%)
Mildly impaired ¼ 2 (7%)
Moderately impaired ¼ 0 (0%)
BCPC, Bidirectional cavopulmonary connection; EDP, end-diastolic pressure; PVR, pulmonary vascular resistance; AVV, atrioventricular valve.
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